Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79944.780.1305%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Medicus Pharma Ltd

MDCXNASDAQ
Trade with Public
Trade with Public
$0.1720
0.00150.88%
At close: Sep 4, 5:00 PM EST
$0.1751
0.00311.8%
After Hours: Sep 4, 7:59 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Medicus Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Medicus Pharma (MDCX).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingBuy# Analysts2Avg. Consensus PT$15Upside to Avg. PT+8181.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Apr 20, 2026D. Boral CapitalJason KolbertMaintainedBuy$9
Mar 19, 2026D. Boral CapitalJason KolbertMaintainedBuy$27
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved